We are taking this opportunity to bring you the latest update on COVID-19 and Nelipak’s response to the ongoing situation. We continue to closely monitor the situation regarding the COVID-19 Coronavirus with the safety and wellbeing of our clients and colleagues remaining our highest priority.
Nelipak is an essential business
Nelipak remains open for business at all ten (10) of our facilities worldwide with no significant supply disruptions. Because Nelipak is in the business of providing sterile barrier packaging for a variety of critical and life-sustaining healthcare applications, our business operations are considered essential and we continue operating in support of our customers and supply chain partners.
Nelipak COVID-19 Related Successes:
In this time of immediate need we are directing product development resources and production capacity to help customers meet the emerging challenges of COVID-19. As a result of the rapid mobilization by our product development and operations teams, we have been able to respond to changing demands in the market for medical and pharmaceutical products.
Our teams continue to demonstrate flexibility in response to the call for much needed PPE supplies. Several of our sites in the US and Ireland have worked with customers to rapid prototype and ramp up manufacturing of much needed face shields to meet increasing market demand.
In addition to the PPE opportunities, we have redirected some of our AVS (Added Value Service) capabilities at our Clara, Ireland site to filling and packaging our customer’s proprietary products which are used in COVID-19 related applications.
Our teams continue to work on these and other exciting projects which both help meet the challenges of COVID-19 and utilize Nelipak open capacity. Talk to our team today to learn how we can assist with your next project.
Supply chain update
We continue to monitor our supply base carefully, our suppliers are communicating, with very limited exception, that the potential risk of disruption remains relatively low.
We thank you for your support to date in reviewing demand and updating us regarding your requirements. However, as you aware, the situation continues to evolve and change with limited notice. Our production priority is to produce and deliver against the firm orders or other agreed upon planning forecasts in our systems. We would encourage you to continue to review any present and future demand for Nelipak products so that we can work with you to mitigate potential supply chain risks.
Our approach to addressing COVID-19
From the onset of the pandemic we implemented a formal COVID-19 monitoring process led by Nelipak global executive leadership and involving a cross-functional team.
We have continued to monitor the situation in the regions where our ten facilities operate including guidance issued by leading health authorities and governmental entities. In response, we have implemented best practice precautionary, preventative and preparedness measures at each of our sites including enhanced site hygiene and cleaning/sanitizing protocols, social distancing measures, site visitor restrictions, and remote work arrangements where appropriate.
We will continue to monitor the COVID-19 situation as it develops and provide updates as appropriate. The health and safety of our employees, customers, suppliers, business partners, and the patients who benefit from our products remains our top priority. If we can answer any questions or be of any assistance, please do not hesitate to ask. Contact us at email@example.com